• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Echo Therapeutics, Inc. (ECTE)

    -NasdaqCM
    2.43 Down 0.07(2.80%) 4:00PM EST
    Add to Portfolio
    Prev Close:2.50
    Open:2.50
    Bid:0.70 x 400
    Ask:199.99 x 1200
    1y Target Est:2.00
    Beta:1.15
    Next Earnings Date:N/A
    Day's Range:2.35 - 2.50
    52wk Range:0.39 - 3.68
    Volume:53,355
    Avg Vol (3m):101,198
    Market Cap:30.69M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ECTE

    Comparison

    Symbol% ChgMkt Cap
    ECTEDown 2.80%30.69M
    ABTDown 0.28%71.06B
    DXCMDown 1.02%4.58B
    MDTDown 1.01%76.77B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,830.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.19
    Quarterly EPS Est (Dec-14) :-0.32
    Mean Recommendation*:5.0
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback